Nuwellis (NUWE) Net Shares Issued and Repurchased (2011 - 2026)
Nuwellis' (NUWE) quarterly Net Shares Issued and Repurchased came in at $768.0 in Q2 2026, up 529.51% on a YoY basis from $122.0 in Q2 2025, and up 12700.0% quarter-over-quarter from $6.0 in Q1 2026.
Analysis
Nuwellis (NUWE) Net Shares Issued and Repurchased (2011 - 2026) Analysis & Trends
Nuwellis (NUWE) has reported Net Shares Issued and Repurchased for 16 consecutive years, with $768.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Net Shares Issued and Repurchased rose 529.51% year-over-year to $768.0; the trailing twelve-month figure through Jun 2026 stood at $768.0 (up 529.51% YoY), and the FY2025 full-year result was $4409.0, up 15646.43% from the prior year.
- Net Shares Issued and Repurchased grew to $768.0 in Q2 2026 per NUWE's latest filing, from $6.0 in the prior quarter.
- Across five years, Net Shares Issued and Repurchased topped out at $95113.0 in Q1 2023 and bottomed at $6.0 in Q1 2026.
- Historically, Net Shares Issued and Repurchased has averaged $7552.9 across 5 years, with a median of $595.0 in 2023.
- The sharpest annual moves came in 2024 and 2025: Net Shares Issued and Repurchased plunged 99.22% in 2024, then jumped 15646.43% in 2025.
- Over 5 years, Net Shares Issued and Repurchased stood at $5833.0 in 2022, then plunged by 38.45% to $3590.0 in 2023, then slumped by 99.22% to $28.0 in 2024, then surged by 15646.43% to $4409.0 in 2025, then plunged by 82.58% to $768.0 in 2026.
- According to Business Quant data, Net Shares Issued and Repurchased over the past three periods registered $768.0, $6.0, and $4409.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | - |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | - |
| 10 | Nuwellis | 140,408.95 | -3.78 Mn | 1.50 Mn | 768.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 768.00 |
| Mar 31, 2026 | 6.00 |
| Dec 31, 2025 | 4,409.00 |
| Sep 30, 2025 | 18.00 |
| Jun 30, 2025 | 122.00 |
| Mar 31, 2025 | 12.00 |
| Dec 31, 2024 | 28.00 |
| Mar 31, 2024 | 1,263.00 |
| Dec 31, 2023 | 3,590.00 |
| Sep 30, 2023 | 595.00 |
| Jun 30, 2023 | 267.00 |
| Mar 31, 2023 | 95,113.00 |
| Dec 31, 2022 | 5,833.00 |
| Sep 30, 2022 | 369.00 |
| Jun 30, 2022 | 900.00 |
| Dec 31, 2021 | 9,081.00 |
| Dec 31, 2020 | 5,542.00 |
| Dec 31, 2019 | 9,374.00 |
| Dec 31, 2018 | 163,997.00 |
| Dec 31, 2017 | 2,461.00 |